Scientists have reported encouraging early tests of a gene therapy strategy against Angelman syndrome, a neurodevelopmental disorder that features poor muscle control and balance, hard-to-treat epilepsy, and intellectual disabilities.
source https://www.sciencedaily.com/releases/2021/10/211022123744.htm
Wednesday, 27 October 2021
Previous Post
Fighting multiple sclerosis with cold
Related Posts
Infrared held in a pincerMany applications, from fiber-optic telecommunications to biomedical i… Read More
3D imaging reveals neural 'vicious cycle' in fatty liver diseaseWith the application of a novel three-dimensional imaging technology, … Read More
Targeted removals and enhanced monitoring can help manage lionfish in the MediterraneanNew research represents one of the first studies to examine the effect… Read More
Antibiotics may help to treat melanomaSome antibiotics appear to be effective against a form of skin cancer … Read More
Scientists develop tougher, safer bicycle helmets using new plastic materialResearchers have developed a tougher, safer bicycle helmet using a com… Read More
Higher levels of omega-3 acids in the blood increases life expectancy by almost five yearsResearchers have found that omega-3 levels in blood erythrocytes are v… Read More
0 comments: